Viewing Study NCT04838860


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-01-05 @ 8:42 PM
Study NCT ID: NCT04838860
Status: TERMINATED
Last Update Posted: 2021-04-19
First Post: 2021-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease
Sponsor: RECORDATI GROUP
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module